GLOPID-R

Wellcome Advancing Zika Virus Research: Key Priorities for Preparedness and Response

In 2023, Wellcome funded the Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota to identify key research priorities for Zika virus preparedness and response. In collaboration with global health experts, this work has now been published as a joint series in The Lancet Infectious Diseases and The Lance Microbe. This work is crucial in shaping the global response to Zika and advancing research to mitigate future risks. Explore the full series on Zika Virus research below:

  1. Zika virus: advancing a priority research agenda for preparedness and response
  2. Zika virus vaccines and monoclonal antibodies: a priority agenda for research and development
  3. Role of non-human primate models in accelerating research and developing countermeasures against Zika virus infection

Specimen and data sharing to advance research and development on Zika virus

Back to Newsletter
EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.